DEPUY SYNTHES SPINE

Manufacturer adverse-event records for DEPUY SYNTHES SPINE come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2012–2019 · thin-book · typical Death-code · balanced

Volume signature

DEPUY SYNTHES SPINE is a thinner MAUDE footprint

DEPUY SYNTHES SPINE accounts for 4,728 FDA MAUDE reports (#371 of 443, thin-book tercile). Death-coded event_type share is 0.68% (typical); Injury share 40.4% (balanced).

What the volume reading shows for DEPUY SYNTHES SPINE

The standout signal for DEPUY SYNTHES SPINE is filing volume: 4,728 adverse-event reports in FDA MAUDE (#371 of 443, thin-book). Death-coded event_type share sits at 0.68% (typical).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Malfunction at 2,782 (58.8% of event_type total). Peak single-year volume reaches 1,080 reports across 8 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,728
Total Reports
32
Event-type Death
1,911
Injury Reports
20
Device Types

Event Types

Malfunction 2,782 (58.8%)
Injury 1,911 (40.4%)
Death 32 (0.7%)
3 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

2,790 (52.7%)
Required Intervention 1,019 (19.3%)
Other 868 (16.4%)
R 532 (10.1%)
Death 30 (0.6%)
O 17 (0.3%)
Hospitalization 15 (0.3%)
S 14 (0.3%)
Life Threatening 5 (0.1%)
Disability 1 (0.0%)

Yearly Trend

12
2012: 15
13
2013: 590
14
2014: 1,071
15
2015: 1,080
16
2016: 946
17
2017: 906
18
2018: 119
19
2019: 1